Your Health, We Care
Release date: 2024-07-10 15:22:40 Recommended: 134
This product, when used in combination with dexamethasone, is suitable for adult patients with recurrent or refractory multiple myeloma who have previously received treatment and are refractory to at least one proteasome inhibitor, one immune modulator, and one anti-CD38 monoclonal antibody.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：208Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：221Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：193Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：159Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：291Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：171Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：326Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：197Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) ···【more】
Recommended：155Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the man···【more】
Recommended：152Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Fo···【more】
Recommended：168Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advance···【more】
Recommended：158Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont···【more】
Recommended：144Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-C···【more】
Recommended：104Release date: 2024-12-13
